(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

A1CARE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

A1CARE

ST13

US500000079386383

Classe

10, 35

Pedido

79386383

Registro

7546958

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

10, 35

Data de depósito

30/08/2023

Data de registro

29/10/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/10/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

GILLES, DEBORAH LYNN MEINERS

Unidade examinadora

M10

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

I-sens, Inc.

Representantes

Sang Ho Lee Bridgeway IP Law Group, PLLC

Classificação técnica

Classes Nice

Classe 10Classe 35

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

Glycated hemoglobin analyzing and measuring apparatus for medical use; medical apparatus and instruments for diabetes management usemedical test kits for diabetes monitoring for home use; lancets; continuous blood glucose monitor for medical use; health monitor sensors for continuous glucose monitoring apparatus; medical apparatus and instruments for monitoring blood glucose levels; needles for medical purposes; apparatus for use in medical analysisapparatus for analyzing blood glucose; blood glucose monitors based on medical sensors; continuous blood monitoring apparatus for medical use; diagnostic apparatus for medical purposesmedical diagnostic apparatus for diagnosing diabetes; cartridges for medical purposescartridges for testing blood being a single-use plastic cartridge sold empty for use with electric monitors; testing apparatus for medical purposes for testing blood; mobile monitoring scanners for measuring blood glucose levels for medical purposes; insulin pen needle sold empty; blood collecting devices for medical purposesneedles and tubes; in vitro diagnostic apparatus for medical purposes for testing blood glucose levels; blood glucose meters; apparatus for blood analysis; blood ketone measuring instruments for medical use

Classe 35

Retail store services featuring software for health care; retail store services featuring computer application software for smartphones featuring diabetes management; retail store services featuring lancets; retail store services featuring medical apparatus and instrumentsnot for dental purposes; retail store services featuring computer software for diagnosing diseases for medical purposes; retail store services featuring alcohol swabs for medical purposes; retail store services featuring precision sensors for medical use; retail store services featuring medical diagnostic test strips; retail store services featuring diagnostic apparatus for medical purposes; retail store services featuring medical diagnostic reagents; retail store services featuring measuring instruments for medical purposes; retail store services featuring insulin penneedle; retail store services featuring electromedical diagnostic instruments; retail store services featuring blood collecting devices; retail store services featuring test strips for measuring blood glucose levels; retail store services featuring blood glucose meters; retail store services featuring blood testing apparatus; retail store services featuring test strips for testing blood; retail store services featuring blood analysis equipment; retail store services featuring blood ketone measuring instruments

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

13/06/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/05/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

27/05/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

19/04/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/04/2025

FIMP

FINAL DISPOSITION PROCESSED

02/04/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

29/01/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

29/10/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

29/10/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/08/2024

PUBO

PUBLISHED FOR OPPOSITION

13/08/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/07/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/06/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/06/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

30/06/2024

RFNT

REFUSAL PROCESSED BY IB

13/06/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

22/05/2024

RFRR

REFUSAL PROCESSED BY MPU

22/05/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/05/2024

CNRT

NON-FINAL ACTION WRITTEN

08/05/2024

DOCK

ASSIGNED TO EXAMINER

11/04/2024

MAFR

APPLICATION FILING RECEIPT MAILED

23/01/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

17/01/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/01/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

28/12/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace A1CARE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.